Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β 论文

2018Scientific Reports引用 360顶会
Alzheimer's disease research and treatmentsComputational Drug Discovery MethodsDrug Transport and Resistance Mechanisms

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β · 相关文章

暂无数据